Astria Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
23 Jan 2026	Form 4: Morabito Christopher, Chief Medical Officer Disposed of 342,500 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jan 2026	Form 4: Milne Jill C., Director Returned 4,377 shares to the issuer · Disposed of 956,000 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jan 2026	Form 4: Violin Jonathan, Director Returned 263,321 shares to the issuer · Acquired 77,249 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jan 2026	Form 4: Lapointe Anthony Gregg, Director Disposed of 79,749 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jan 2026	Form 4: Komjathy Andrew, Chief Commercial Officer Returned 100 shares to the issuer · Disposed of 280,000 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jan 2026	Form 4: Harshbarger Benjamin, Chief Legal Officer Disposed of 350,833 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jan 2026	Form 4: Kishbauch Michael D, Director Disposed of 79,749 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jan 2026	Form 4: Cole Hugh M, Director Disposed of 79,749 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jan 2026	Form 4: Matthews Andrea, Chief Business Officer Disposed of 315,312 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jan 2026	Form 4: Clauser Noah, Chief Financial Officer Disposed of 317,500 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jan 2026	Form 4: Callori Fred, Director Disposed of 77,249 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jan 2026	Form 4: Beck Joanne T., Director Disposed of 79,749 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jan 2026	Form 4: Bate Kenneth, Director Disposed of 79,749 Stock Option (Right to Buy) (Disposition to Issuer)
23 Jan 2026	Form 4: Agarwal Sunil, Director Disposed of 54,750 Stock Option (Right to Buy) (Disposition to Issuer)
12 Jun 2025	Form 4: Agarwal Sunil, Director Granted 26,550 Stock Option (Right to Buy)
12 Jun 2025	Form 4: Bate Kenneth, Director Granted 26,550 Stock Option (Right to Buy)
12 Jun 2025	Form 4: Cole Hugh M, Director Granted 26,550 Stock Option (Right to Buy)
12 Jun 2025	Form 4: Kishbauch Michael D, Director Granted 26,550 Stock Option (Right to Buy)
12 Jun 2025	Form 4: Lapointe Anthony Gregg, Director Granted 26,550 Stock Option (Right to Buy)
12 Jun 2025	Form 4: Violin Jonathan, Director Granted 26,550 Stock Option (Right to Buy)

Comments